drugset / Trial / NCT04120597

Clinical and Basic Research on the Treatment of Polycystic Ovary Syndrome

NCT04120597 ↗

Phase 1/2 Completed 126 enrolled Jiangxi University of Traditional Chinese Medicine
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Polycystic ovary syndrome is the most common endocrine and metabolic disorder in gynecology. Traditional Chinese medicine has a good clinical effect in the treatment of PCOS. We intend to conduct this trial in strict accordance with the requirements of evidence-based medicine, through a multi-center, randomized, controlled study, using a double-blind, randomized, placebo-controlled study design method to clarify that Zishen Qingre Lishi Huayu Recipe restores spontaneous ovulation in PCOS patients. The overall efficacy of improving the characteristics of Kaohsiung and glucose and lipid metabolism is optimal, and high-level evidence-based evidence is obtained to form a diagnosis and treatment plan for promotion.

Timeline

Start
2019-12-23
Primary completion
2021-08-20
Completion
2021-09-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Zishen Qingre Lishi Huayu Granules Unknown — —